Conference Coverage

VIDEO: Management of difficult-to-treat IBD cases


 

EXPERT ANALYSIS FROM DIGESTIVE DISEASES: NEW ADVANCES

PHILADELPHIA – The lack of evidence-based management strategies for the treatment of difficult inflammatory bowel disease cases, such as with Crohn’s disease, can lead to confusion for some clinicians.

Dr. Mark T. Osterman, assistant professor of medicine at the University of Pennsylvania, Philadelphia, discusses when to use antibiotics in Crohn’s disease and when to consider antibiotics in combination with draining fistulae. He also discusses available pharmacotherapies, and the value of bowel rest.

“The best treatment of all for difficult inflammatory bowel disease is aggressive and early, so that the condition doesn’t go from bad to worse,” Dr. Osterman said.

The video was recorded at this year’s meeting of Digestive Diseases: New Advances, a meeting held by Global Academy for Medical Education and Rutgers, the State University of New Jersey. Global Academy and this news organization are owned by the same company.

The video associated with this article is no longer available on this site. Please view all of our videos on the MDedge YouTube channel.

wmcknight@frontlinemedcom.com

On Twitter @whitneymcknight

Recommended Reading

Factors within VA control could help prevent missed, canceled appointments
HCV Hub
Drug combo held up in real-world HCV study
HCV Hub
Minor residual staining found adequate for colonoscopy
HCV Hub
MRI topped transient elastography for staging nonalcoholic fatty liver disease
HCV Hub
Trial results for hepatitis C antivirals not generalizable to coinfected HIV/HCV patients
HCV Hub
Lessons from the Indiana HIV/HCV outbreak
HCV Hub
VIDEO: Rectal indomethacin does not prevent pancreatitis post ERCP
HCV Hub
VIDEO: Newer MRI hardware, software significantly better at detecting pancreatic cysts
HCV Hub
Birth-cohort HCV testing misses one-quarter of infections
HCV Hub
Privacy measure inadvertently suppresses substance abuse data
HCV Hub